Efficacy of Atorvastatin Loaded on Nano Particles on Cryptosporidium Parvum in Experimentally Infected Mice

EVALUATION OF LACTOBACILLUS ACIDOPHILUS, CHITOSAN AND/OR AZITHROMYCIN IN TREATING CRYPTOSPORIDIOSIS IN NEONATAL MICE

Evaluation of potential prophylactic and therapeutic effect of azoximer bromide (polyoxidonium) on experimental cryptosporidiosis in immunocompromised mice

IN VIVO ASSESSMENT OF ROSUVASTATIN EFFICACY ON EXPERIMENTAL MURINE WITH AVIRULENT TOXOPLASMOSIS

AMELIORATING EFFECT OF NITAZOXANIDE LOADED CHITOSAN NANOPARTICLES ON INTESTINAL DYSPLASTIC CHANGES IN IMMUNOSUPPRESSED CRYPTOSPORIDIOSIS MURINE MODEL

IVERMECTIN WITH NITAZOXANIDE ELIMINATE CRYPTOSPORIDIUM INTESTINAL INFECTION IN IMMUNOCOMPROMIZED MICE AND UPREGULATE CYTOKERATIN20 EXPRESSION, ENHANCING INTESTINAL CELLULAR HEALIN

Control of the Waterborne Cryptosporidiosis: Evaluation of the Protective Role of Cryptosporidium parvum Oocysts Antigen in Infected Immunocompetent and Immunosuppressed Mice

EFFECT OF SOME MEDICINAL HERBS VERSUS NITAZOXANIDE ON CRYPTOSPORIDIUM PARVUM INFECTED IMMUNOSUPPRESSED MICE

POTENTIAL IMMUNOMODULATORY EFFECT OF SINGLE AND COMBINED THERAPIES AGAINST CRYPTOSPORIDIUM INFECTION IN IMMUNOSUPPRESSED MOUSE MODEL

IN VITRO STUDY ON THE ANTIPARASITIC EFFECT OF OMEPRAZOLE ON CRYPTOSPORIDIUM PARVUM